What is the likely diagnosis for a patient with positive Smith (SM) antibodies, Smith-Ribonucleoprotein (SMRNP), Ribonucleoprotein (RNP), and Sjögren's syndrome antigen A (SS-A) on a chromatin Bioplex (Bioplex) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis

The patient's positive test results for SM Bioplex, SMRNP, RNP, SS-A, and chrom Bioplex suggest an autoimmune disorder. Here's a categorized differential diagnosis:

  • Single most likely diagnosis
    • Systemic Lupus Erythematosus (SLE): The presence of multiple positive autoantibodies, including SM, SMRNP, RNP, and SS-A, is highly suggestive of SLE. This condition is a chronic autoimmune disease that can affect multiple organs and systems.
  • Other Likely diagnoses
    • Mixed Connective Tissue Disease (MCTD): The combination of positive RNP, SMRNP, and SS-A antibodies can also be seen in MCTD, which is an autoimmune disorder that overlaps with SLE, scleroderma, and polymyositis.
    • Sjögren's Syndrome: The presence of SS-A antibodies is commonly associated with Sjögren's Syndrome, an autoimmune disorder that primarily affects the exocrine glands, particularly the salivary and lacrimal glands.
  • Do Not Miss (ddxs that may not be likely, but would be deadly if missed.)
    • Neonatal Lupus: Although rare, neonatal lupus can occur in infants born to mothers with SLE or SS-A antibodies. It's essential to consider this diagnosis if the patient is pregnant or has a history of pregnancy complications.
    • Undifferentiated Connective Tissue Disease (UCTD): UCTD is a condition that does not meet the full criteria for a specific autoimmune disease but can still cause significant morbidity. It's crucial to monitor patients with UCTD for potential progression to a more defined autoimmune disorder.
  • Rare diagnoses
    • Scleroderma: While the patient's antibody profile is not typical for scleroderma, it's essential to consider this diagnosis, especially if there are symptoms such as skin thickening, esophageal dysmotility, or pulmonary hypertension.
    • Polymyositis/Dermatomyositis: These inflammatory myopathies can present with overlapping features of autoimmune disorders, including positive autoantibodies. However, the patient's antibody profile is not strongly suggestive of these conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.